cladribine has been researched along with Disease, Pulmonary in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lorillon, G; Tazi, A | 1 |
| Bosdure, E; Donadieu, J; Galambrun, C; Garaix, F; Mace, L; Petit, P; Picard, C; Poullin, P; Stremler, N; Ughetto, F | 1 |
| Cordier, JF; Cottin, V; Grobost, V; Khouatra, C; Lazor, R | 1 |
| Broijl, A; Hermans, MA; van Daele, PL | 1 |
| Brodie, GN; Goh, NS; MacGregor, DP; McDonald, CE; Pretto, JJ | 1 |
| Bartkowiak, J; Bednarek, A; Chojnowski, K; Chudobinski, C; Kordek, R; Robak, P; Robak, T; Urbanska-Rys, H | 1 |
| Burian, C; Saven, A | 1 |
1 review(s) available for cladribine and Disease, Pulmonary
| Article | Year |
|---|---|
How I manage pulmonary Langerhans cell histiocytosis.
Topics: Adult; Cladribine; Female; Genetic Predisposition to Disease; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Lung; Lung Diseases; Lung Transplantation; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Phenotype; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Respiratory Function Tests; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2017 |
1 trial(s) available for cladribine and Disease, Pulmonary
| Article | Year |
|---|---|
Cladribine activity in adult langerhans-cell histiocytosis.
Topics: Adult; Aged; Bone Diseases; Cladribine; Female; Histiocytosis, Langerhans-Cell; Humans; Lung Diseases; Lymphatic Diseases; Male; Middle Aged; Skin Diseases | 1999 |
5 other study(ies) available for cladribine and Disease, Pulmonary
| Article | Year |
|---|---|
Cladribine-related immunosuppression may have fostered graft-versus-host disease after lung transplant for pulmonary Langerhans cell histiocytosis.
Topics: Child, Preschool; Cladribine; Fatal Outcome; Female; Graft vs Host Disease; Histiocytosis, Langerhans-Cell; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lung Diseases; Lung Transplantation | 2019 |
Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.
Topics: Adult; Antineoplastic Agents; Cladribine; Female; Histiocytosis, Langerhans-Cell; Humans; Lung Diseases; Male; Middle Aged; Retrospective Studies; Smoking; Treatment Outcome | 2014 |
A unique presentation of pulmonary disease in advanced systemic mastocytosis, proven by the presence of mast cells in bronchoalveolar lavage: a case report.
Topics: Adult; Anemia; Anti-Inflammatory Agents; Antineoplastic Agents; Bronchoalveolar Lavage; Cladribine; Down Syndrome; Fatal Outcome; Female; Humans; Leukemoid Reaction; Lung Diseases; Mastocytosis, Systemic; Prednisolone; Sepsis | 2016 |
Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine.
Topics: Adult; Antineoplastic Agents; Biopsy, Needle; Cladribine; Drug Administration Schedule; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Immunohistochemistry; Infusions, Intravenous; Lung Diseases; Male; Respiratory Function Tests; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
High activity of rituximab combined with cladribine and cyclophosphamide in a patient with pulmonary lymphomatoid granulomatosis and bone marrow involvement.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cladribine; Cyclophosphamide; Female; Humans; Lung Diseases; Lymphomatoid Granulomatosis; Middle Aged; Rituximab | 2006 |